NISHA PANDAY: Open Payments
NPI 1124484399 · GREENVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$263 in 15 payments from 10 companies in 2025. Trend: 2023 $934 · 2024 $280 · 2025 $263
Food & beverage: $263
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $63 |
| Novo Nordisk Inc | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| BridgeBio Pharma, Inc. | 1 | $21 |
| SCPHARMACEUTICALS INC. | 1 | $21 |
| Amgen Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Boston Scientific Corporation | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: ELIQUIS, Ozempic, Kerendia, Attruby, FUROSCIX, REPATHA, SHINGRIX, CDS - MCT/CEM Monitoring.
Industry payments across OH — which companies pay providers there.
